Novel Technologies for percutaneous treatment of tricuspid valve regurgitation
Sign Up to like & getrecommendations! Published in 2017 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehx475
Abstract: Tricuspid regurgitation (TR) is mostly secondary to annular dilatation and/or leaflet tethering, in the absence of organic valve lesions or, as a result of left-sided heart valve disease, atrial fibrillation, or pulmonary hypertension, [functional TR… read more here.
Keywords: regurgitation; novel technologies; percutaneous treatment; technologies percutaneous ... See more keywords